39 studies found for: Open Studies | "beta-Thalassemia"
HSCT For Patients With High Risk Hemoglobinopathies Using Reduced Intensity
B-Thalasaemia Trait and Its Possible Cardioprotective Role
Decision Aid for Therapeutic Options In Sickle Cell Disease
Detection of β Thalassemia Carriers by Red Cell Parameters Obtained From the H2 Automatic Counter
A Case Control Study to Evaluate the Cognitive and Brain Function of β-thalassemia Patients.
Nonmyeloablative Haploidentical Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Severe Congenital Anemias Including Sickle Cell Disease and Beta-Thalassemia
|27||Not yet recruiting||
Role of Vitamin C to Augment Iron Chelation With DFP or DFX
Therapeutic Effect and Safety of Combined Hydroxyurea With Recombinant Human Erythropoietin.
Study of Efficacy and Safety of INC424 in Regularly Transfused Patients With Thalassemia.
The Effect of Vitamin D Supplementation on Calcium Excretion in Thalassemia: a Dose Response Study
High-Tc Susceptometer to Monitor Transfusional Iron Overload
Combination Deferasirox and Deferiprone for Severe Iron Overload in Thalassemia
GDF 15 in Sickle Cell Disease and Hereditary Spherocytosis
Nonmyeloablative Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Sickle Cell Disease and Beta-thalassemia in People With Higher Risk of Transplant Failure
Interferon and Ribavirin Treatment in Patients With Hemoglobinopathies
|36||Not yet recruiting||
Efficacy/Safety Study of Deferiprone Compared to Deferasirox in Paediatric Patients
Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell Transplant
Reduced Intensity Conditioning in Patients Aged ≤35 With Non-Malignant Disorders Undergoing UCBT, BMT, or PBSCT
† Indicates status has not been verified in more than two years